SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-186692
Filing Date
2021-06-09
Accepted
2021-06-09 16:01:33
Documents
14
Period of Report
2021-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d177146d8k.htm   iXBRL 8-K 39767
2 EX-99.1 d177146dex991.htm EX-99.1 1986
3 EX-99.2 d177146dex992.htm EX-99.2 32498
  Complete submission text file 0001193125-21-186692.txt   206543

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210609.xsd EX-101.SCH 3081
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210609_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210609_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d177146d8k_htm.xml XML 3271
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 211005133
SIC: 2834 Pharmaceutical Preparations